Exploring perceptions of and decision‐making about CFTR modulators
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Lee Landess, Mary G. Prieur, Ashley R. Brown, Elisabeth P. Dellon |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Effects on growth, weight and body composition after CFTR modulators in children with cystic fibrosis
by: CM. López Cárdenes, et al.
Published: (2024)
by: CM. López Cárdenes, et al.
Published: (2024)
MLPA‐Detected CFTR Exon Deletions in Children With Inconclusive CFTR Sequencing: A Single‐Center Experience From Türkiye
by: Sanem Eryılmaz Polat, et al.
Published: (2026)
by: Sanem Eryılmaz Polat, et al.
Published: (2026)
The rebound effect: Reoccurrence of nasal polyps following discontinuation of a CFTR modulator in a patient with cystic fibrosis sinus disease
by: Brittany A. Wright, et al.
Published: (2024)
by: Brittany A. Wright, et al.
Published: (2024)
CFTR Modulators in Brazil: Not for Everyone—A Comparison of Ineligibility Across Different Regions
by: Edna Lúcia D' Souza, et al.
Published: (2026)
by: Edna Lúcia D' Souza, et al.
Published: (2026)
Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk
by: Tyler Shugg, et al.
Published: (2025)
by: Tyler Shugg, et al.
Published: (2025)
Baseline Characteristics and Self‐Reported Use of Chronic Daily Therapies of the Home Reported Outcomes With CFTR Modulator Therapy (HERO‐2) Cohort
by: Georgene E. Hergenroeder, et al.
Published: (2025)
by: Georgene E. Hergenroeder, et al.
Published: (2025)
Exocrine Pancreatic Function in Pediatric Patients After Two Years of Triple CFTR Modulator Therapy: Is It Possible to Restore Pancreatic Function?
by: C. M. López Cárdenes, et al.
Published: (2026)
by: C. M. López Cárdenes, et al.
Published: (2026)
Tracheostomy and long‐term invasive ventilation decision‐making in children: A scoping review
by: Cheryl Mack, et al.
Published: (2024)
by: Cheryl Mack, et al.
Published: (2024)
Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in a man with A559T and 3120+1G>CFTR variants
by: Emily Mitchell, et al.
Published: (2024)
by: Emily Mitchell, et al.
Published: (2024)
Current Status and the Need for CFTR Modulator Therapy in Cystic Fibrosis Patients in Mainland China: A Case Report and Literature Review
by: Yuxiao Sun, et al.
Published: (2026)
by: Yuxiao Sun, et al.
Published: (2026)
Genetic counseling access and service delivery in New York State is variable for parents of infants with complex CFTR genotypes conferring uncertain phenotypes
by: Denise M. Kay, et al.
Published: (2024)
by: Denise M. Kay, et al.
Published: (2024)
New York cystic fibrosis consortium newborn screening quality improvement: Development and implementation of a statewide consensus recommendations for management of infants with CFTR‐related metabolic syndrome
by: Saroj Choudhary, et al.
Published: (2024)
by: Saroj Choudhary, et al.
Published: (2024)
Elexacaftor/Tezacaftor/Ivacaftor Effect on a Patient With Rare Compound Heterozygous CFTR Splice Variant Genotype C.[1393‐1G>A;2988+1G>A]
by: Maria Moustaki, et al.
Published: (2025)
by: Maria Moustaki, et al.
Published: (2025)
Nebulized Treprostinil in Mechanically Ventilated Children
by: Sarah P. Cohen, et al.
Published: (2025)
by: Sarah P. Cohen, et al.
Published: (2025)
Pilot testing of “A NICU guide to tracheostomy”
by: Kylie M. Bushroe, et al.
Published: (2024)
by: Kylie M. Bushroe, et al.
Published: (2024)
The incidental pediatric pulmonary nodule: What to ignore, what to worry about
by: R. Paul Guillerman
Published: (2024)
by: R. Paul Guillerman
Published: (2024)
Predicting weight gain in patients with cystic fibrosis on triple combination modulator
by: Kelly L. Stewart, et al.
Published: (2024)
by: Kelly L. Stewart, et al.
Published: (2024)
Families' perceptions of consumer‐grade, inexpensive oxygen saturation monitors
by: Danielle Charland, et al.
Published: (2024)
by: Danielle Charland, et al.
Published: (2024)
XRAInet: AI‐based decision support for pneumothorax and pleural effusion management
by: Mustafa Alper Akay, et al.
Published: (2024)
by: Mustafa Alper Akay, et al.
Published: (2024)
The gastrointestinal microbiome, small bowel bacterial overgrowth, and microbiome modulators in cystic fibrosis
by: Nicole Green, et al.
Published: (2024)
by: Nicole Green, et al.
Published: (2024)
Overnutrition in persons with cystic fibrosis on modulator therapy and the relationship to obstructive sleep apnea
by: Aesha M. Jobanputra, et al.
Published: (2024)
by: Aesha M. Jobanputra, et al.
Published: (2024)
Adding fuel to the fire: The growing case for global access to cystic fibrosis transmembrane conductance regulator modulator therapy
by: Brenda M. Morrow, et al.
Published: (2024)
by: Brenda M. Morrow, et al.
Published: (2024)
Diagnosis and treatment of ADHD in pediatric patients during the first year of elexacaftor/tezacaftor/ivacaftor
by: Kimberly Pasley, et al.
Published: (2024)
by: Kimberly Pasley, et al.
Published: (2024)
Creating a Risk Score for Prolonged Length of Stay Following Pediatric Lung Transplants
by: Michael DiLeo, et al.
Published: (2024)
by: Michael DiLeo, et al.
Published: (2024)
Wheezing Episodes in Children Before and After the Onset of the COVID‐19 Pandemic in Brussels
by: Clementine Delporte, et al.
Published: (2025)
by: Clementine Delporte, et al.
Published: (2025)
Novel Use of Cryotherapy for Treatment and Diagnosis of Intrathoracic Nontuberculous Mycobacteria Infections in Children: A Case Series
by: Ye Sun, et al.
Published: (2025)
by: Ye Sun, et al.
Published: (2025)
“We Could Hold Our Own Here at Home”: Longitudinal Experience of COVID‐19 Lockdowns in Parents With Children Affected With Interstitial Lung Disease
by: Carlee Gilbert, et al.
Published: (2024)
by: Carlee Gilbert, et al.
Published: (2024)
Acute exposure to pollen and airway inflammation in adolescents
by: Nicholas J. Nassikas, et al.
Published: (2024)
by: Nicholas J. Nassikas, et al.
Published: (2024)
Facilitators and Barriers to Increasing Equity in Cystic Fibrosis Newborn Screening Algorithms
by: Kellyn Madden, et al.
Published: (2024)
by: Kellyn Madden, et al.
Published: (2024)
Exploring research trends and hotspots on oxidative stress and bronchopulmonary dysplasia: Insights from bibliometric and visualized study
by: Liyan Luo, et al.
Published: (2024)
by: Liyan Luo, et al.
Published: (2024)
Prevalence of cannabidiol use in persons with cystic fibrosis
by: Emma M. Tillman, et al.
Published: (2024)
by: Emma M. Tillman, et al.
Published: (2024)
Prevalence, stability, and clinical significance of an isolated low FEV1 spirometry pattern in children
by: MacKenzie L. Wyatt, et al.
Published: (2024)
by: MacKenzie L. Wyatt, et al.
Published: (2024)
Exploring Risk Factors Associated With Intensive Care Unit Admission in a Retrospective Cohort of 631 Children With Bronchiolitis
by: Valentina Guarnieri, et al.
Published: (2024)
by: Valentina Guarnieri, et al.
Published: (2024)
Exploring the Causal Association Between Oral Microbiome Abundance and Asthma Risk Using Two‐Sample Mendelian Randomization
by: Huagui Han, et al.
Published: (2025)
by: Huagui Han, et al.
Published: (2025)
Home spirometry monitoring to identify loss of asthma control in adolescents
by: Allison J. Burbank, et al.
Published: (2024)
by: Allison J. Burbank, et al.
Published: (2024)
Exploration of MyVoice: CF as a Reproductive Health Decision Support Tool for Adolescent Females With Cystic Fibrosis
by: Maya L. Albanowski, et al.
Published: (2025)
by: Maya L. Albanowski, et al.
Published: (2025)
Exploring Bone Health in Cystic Fibrosis: A Study From a Lung Transplantation Center and Strategy for Clinical Care
by: Gökçen Kartal Öztürk, et al.
Published: (2025)
by: Gökçen Kartal Öztürk, et al.
Published: (2025)
Exploring Exercise as Airway Clearance in Cystic Fibrosis: A Qualitative Study From the ExACT‐CF Feasibility Trial
by: Emily Taylor, et al.
Published: (2026)
by: Emily Taylor, et al.
Published: (2026)
“I eat chocolate milk for dinner because we just have nothing in our fridge”: The invisible burden and dire consequences of food insecurity for people with cystic fibrosis in the United States
by: Soumya J. Niranjan, et al.
Published: (2024)
by: Soumya J. Niranjan, et al.
Published: (2024)
Mental Health of Pediatric Patients with Cystic Fibrosis after 18 Months on Elexacaftor‐Tezacaftor‐Ivacaftor Therapy
by: Kimberly Pasley, et al.
Published: (2024)
by: Kimberly Pasley, et al.
Published: (2024)
Similar Items
-
Effects on growth, weight and body composition after CFTR modulators in children with cystic fibrosis
by: CM. López Cárdenes, et al.
Published: (2024) -
MLPA‐Detected CFTR Exon Deletions in Children With Inconclusive CFTR Sequencing: A Single‐Center Experience From Türkiye
by: Sanem Eryılmaz Polat, et al.
Published: (2026) -
The rebound effect: Reoccurrence of nasal polyps following discontinuation of a CFTR modulator in a patient with cystic fibrosis sinus disease
by: Brittany A. Wright, et al.
Published: (2024) -
CFTR Modulators in Brazil: Not for Everyone—A Comparison of Ineligibility Across Different Regions
by: Edna Lúcia D' Souza, et al.
Published: (2026) -
Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk
by: Tyler Shugg, et al.
Published: (2025)